Literature DB >> 25270497

Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness.

Colleen L Barry, Emma E McGinty, Bernice A Pescosolido, Howard H Goldman.   

Abstract

OBJECTIVE: Public attitudes about drug addiction and mental illness were compared.
METHODS: A Web-based national survey (N=709) was conducted to compare attitudes about stigma, discrimination, treatment effectiveness, and policy support in regard to drug addiction and mental illness.
RESULTS: Respondents held significantly more negative views toward persons with drug addiction. More respondents were unwilling to have a person with drug addiction marry into their family or work closely with them. Respondents were more willing to accept discriminatory practices against persons with drug addiction, more skeptical about the effectiveness of treatments, and more likely to oppose policies aimed at helping them.
CONCLUSIONS: Drug addiction is often treated as a subcategory of mental illness, and insurance plans group them together under the rubric of "behavioral health." Given starkly different public views about drug addiction and mental illness, advocates may need to adopt differing approaches to reducing stigma and advancing public policy.

Entities:  

Mesh:

Year:  2014        PMID: 25270497      PMCID: PMC4285770          DOI: 10.1176/appi.ps.201400140

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  5 in total

1.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

Authors:  R C Kessler; C B Nelson; K A McGonagle; M J Edlund; R G Frank; P J Leaf
Journal:  Am J Orthopsychiatry       Date:  1996-01

2.  Experiences of stigma and access to HAART in children and adolescents living with HIV/AIDS in Brazil.

Authors:  César Ernesto Abadía-Barrero; Arachu Castro
Journal:  Soc Sci Med       Date:  2005-08-15       Impact factor: 4.634

3.  "A disease like any other"? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence.

Authors:  Bernice A Pescosolido; Jack K Martin; J Scott Long; Tait R Medina; Jo C Phelan; Bruce G Link
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

4.  Public conceptions of mental illness: labels, causes, dangerousness, and social distance.

Authors:  B G Link; J C Phelan; M Bresnahan; A Stueve; B A Pescosolido
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

5.  The impact of universal access to antiretroviral therapy on HIV stigma in Botswana.

Authors:  William R Wolfe; Sheri D Weiser; Karen Leiter; Wayne T Steward; Fiona Percy-de Korte; Nthabiseng Phaladze; Vincent Iacopino; Michele Heisler
Journal:  Am J Public Health       Date:  2008-08-13       Impact factor: 9.308

  5 in total
  91 in total

1.  Effects of Global Payment and Accountable Care on Medication Treatment for Alcohol and Opioid Use Disorders.

Authors:  Julie M Donohue; Colleen L Barry; Elizabeth A Stuart; Shelly F Greenfield; Zirui Song; Michael E Chernew; Haiden A Huskamp
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

2.  Medical Disease or Moral Defect? Stigma Attribution and Cultural Models of Addiction Causality in a University Population.

Authors:  Nicole L Henderson; William W Dressler
Journal:  Cult Med Psychiatry       Date:  2017-12

3.  Strategies used by people who inject drugs to avoid stigma in healthcare settings.

Authors:  Dea L Biancarelli; Katie B Biello; Ellen Childs; M Drainoni; Peter Salhaney; Alberto Edeza; Matthew J Mimiaga; Richard Saitz; Angela R Bazzi
Journal:  Drug Alcohol Depend       Date:  2019-03-08       Impact factor: 4.492

4.  Development of a Cascade of Care for responding to the opioid epidemic.

Authors:  Arthur Robin Williams; Edward V Nunes; Adam Bisaga; Frances R Levin; Mark Olfson
Journal:  Am J Drug Alcohol Abuse       Date:  2019-01-24       Impact factor: 3.829

5.  Biased labels: An experimental study of language and stigma among individuals in recovery and health professionals.

Authors:  Robert D Ashford; Austin M Brown; Jessica McDaniel; Brenda Curtis
Journal:  Subst Use Misuse       Date:  2019-04-04       Impact factor: 2.164

Review 6.  A Dissemination and Implementation Science Approach to the Epidemic of Opioid Use Disorder in the United States.

Authors:  Stephanie M Mathis; Nicholas Hagemeier; Angela Hagaman; John Dreyzehner; Robert P Pack
Journal:  Curr HIV/AIDS Rep       Date:  2018-10       Impact factor: 5.071

7.  The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral healthcare utilization and spending among enrollees with substance use disorders.

Authors:  Sarah Friedman; Haiyong Xu; Jessica M Harwood; Francisca Azocar; Brian Hurley; Susan L Ettner
Journal:  J Subst Abuse Treat       Date:  2017-06-26

8.  Waking Up from Dreamland: Opioid Addiction Precipitance and Support for Redistributive Drug Treatment.

Authors:  David Chavanne; Kimberly Goodyear
Journal:  J Drug Policy Anal       Date:  2020-05-18

9.  Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.

Authors:  Jennifer Miles; Jason Howell; Dave Sheridan; George Braucht; Amy Mericle
Journal:  Am J Drug Alcohol Abuse       Date:  2020-02-24       Impact factor: 3.829

Review 10.  Behavioral Genetics in Criminal and Civil Courts.

Authors:  Maya Sabatello; Paul S Appelbaum
Journal:  Harv Rev Psychiatry       Date:  2017 Nov/Dec       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.